Summary

Persistence Market Research has recently published a comprehensive report on the global Psychedelic API Market. This report provides an in-depth analysis of crucial market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

• Psychedelic API Market Size (2024E): USD 1.9 Bn
• Projected Market Value (2033F): USD 6.1 Bn
• Global Market Growth Rate (CAGR 2024-2033):13.60%

Psychedelic API Market - Report Scope:

Psychedelic APIs (Active Pharmaceutical Ingredients) are gaining recognition for their therapeutic potential in treating mental health and neurological conditions. This market encompasses the development and production of APIs used in psychedelic drugs such as psilocybin, MDMA, and DMT, which are being investigated for their efficacy in treating conditions like depression, PTSD, and anxiety. The market's growth is driven by increasing research and clinical trials, rising acceptance of psychedelic therapies, and advancements in drug development technologies.

Market Growth Drivers:

Several key factors drive the global psychedelic API market. Growing interest and investment in psychedelic research for mental health treatments play a significant role in market expansion. The rising prevalence of mental health disorders and the limitations of traditional therapies lead to a higher demand for novel treatments. Regulatory changes and increasing acceptance of psychedelic therapies in various regions also contribute to market growth. Furthermore, advancements in drug formulation and delivery technologies are opening new opportunities in the psychedelic API market.

Market Restraints:

Despite promising growth, the psychedelic API market faces challenges such as regulatory hurdles, legal restrictions, and high research and development costs. Regulatory bodies in different countries impose stringent guidelines and approval processes for psychedelic drugs, which can delay market entry. Legal uncertainties and social stigmas associated with psychedelics can impede market progress. Additionally, the high costs of R&D and clinical trials can affect profitability and market viability.

Market Opportunities:

The psychedelic API market presents significant growth opportunities driven by evolving therapeutic applications, increasing investment in psychedelic research, and expanding global markets. The potential of psychedelics to treat a variety of mental health disorders opens new avenues for market growth. Additionally, partnerships between pharmaceutical companies, research institutions, and technology providers are fostering innovation and development. Expanding regulatory frameworks and growing public acceptance are also paving the way for market expansion and new product introductions.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the psychedelic API market globally?
• Which therapeutic applications are leading the adoption of psychedelic APIs?
• How are advancements in drug development influencing the competitive landscape of the psychedelic API market?
• Who are the key players in the psychedelic API market, and what strategies are they employing to maintain their market position?
• What are the emerging trends and future prospects in the global psychedelic API market?

Competitive Intelligence and Business Strategy:

Leading players in the global psychedelic API market, such as COMPASS Pathways, MindMed, and Cybin, focus on innovation, strategic partnerships, and regulatory compliance to gain a competitive advantage. These companies invest heavily in R&D to advance psychedelic therapies and expand clinical trials. Collaborations with research institutions and healthcare providers enhance market access and support the development of new treatments. Additionally, navigating regulatory landscapes and addressing societal concerns strengthens market positioning.

Key Companies Profiled:

• Core One Labs Inc.
• Cayman Chemical Company (Matreya)
• COMPASS Pathways plc
• Beckley Psytech
• Atai Life Sciences
• Tryp Therapeutics
• Filament Health
• Ceruvia Lifesciences, LLC
• BetterLife Pharma
• Psygen Pharmaceutical
• Mindset Pharma

Key Segments of Psychedelic API Industry Research

Product:

• API-Grade Psilocybin
• API-Grade DMT
• LSD API
• MDMA API
• Ketamine API
• Others

API Compound:

• Active Plant Components
• Novel Synthetic Compounds
• Metabolites
• Isotopically Labelled Standards

Source:

• Natural
• Synthetic
• Bio-Synthetic

Grade:

• GMP
• Non-GMP

Application:

• Clinical
• Research

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Production Strategy
4.2. Volume Consumption
4.3. Production Cost
4.4. Disease Epidemiology
4.5. Regulatory Scenario
4.6. Pipeline Assessment
4.7. Patent Analysis
4.8. PESTEL Analysis
4.9. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Psychedelic Drugs Industry Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Development of Novel Products
5.2.2. Regulatory Imposition
5.2.3. Increasing Spending on Targeted Therapies
5.2.4. Increasing Prevalence Of Depression And Mental Disorders
5.2.5. Strategic Mergers and Acquisitions Among Local
5.2.6. Rising Awareness Towards Mental Health
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.2. 2024 Market Scenario
7. Global Psychedelic API Market Volume (in Kgs) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Volume (in Kgs) Analysis, 2019-2023
7.2. Current and Future Market Volume (in Kgs) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Psychedelic API Market- Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Price Break up
8.2.1. Manufacturer Level
8.2.2. Distributor Level
8.3. Global Average Pricing Analysis Benchmark
8.3.1. Pricing Assumptions
9. Global Psychedelic API Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Psychedelic API Market Analysis 2019-2023 and Forecast 2024-2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) and Volume (in Kgs) Analysis By Product, 2019-2023
10.3. Current and Future Market Size (US$ Bn) and Volume (in Kgs) Analysis and Forecast By Product, 2024-2033
10.3.1. API-Grade Psilocybin
10.3.2. API-Grade DMT
10.3.3. LSD API
10.3.4. MDMA API
10.3.5. Ketamine API
10.3.6. Others
10.4. Market Attractiveness Analysis By Product
11. Global Psychedelic API Market Analysis 2019-2023 and Forecast 2024-2033, By API Compounds
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis, By API Compounds, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By API Compounds, 2024-2033
11.3.1. Active Plant Components
11.3.2. Novel Synthetic Compounds
11.3.3. Metabolites
11.3.4. Isotopically Labeled Standards
11.4. Market Attractiveness Analysis By API Compounds
12. Global Psychedelic API Market Analysis 2019-2023 and Forecast 2024-2033, By Source
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Bn) Analysis, By Source, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Source, 2024-2033
12.3.1. Natural
12.3.2. Synthetic
12.3.3. Bio-Synthetic
12.4. Market Attractiveness Analysis By Source
13. Global Psychedelic API Market Analysis 2019-2023 and Forecast 2024-2033, By Grade
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Bn) Analysis, By Grade, 2019-2023
13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Grade, 2024-2033
13.3.1. Natural
13.3.2. Synthetic
13.3.3. Bio-Synthetic
13.4. Market Attractiveness Analysis By Grade
14. Global Psychedelic API Market Analysis 2019-2023 and Forecast 2024-2033, By Application
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
14.3.1. Natural
14.3.2. Synthetic
14.3.3. Bio-Synthetic
14.4. Market Attractiveness Analysis By Application
15. Global Psychedelic API Market Analysis 2019-2023 and Forecast 2024-2033, By Region
15.1. Introduction
15.2. Historical Market Size (US$ Bn) and Volume (in Kgs) Analysis By Region, 2019-2023
15.3. Current and Future Market Value (US$ Bn) and Volume (in Kgs) Analysis and Forecast, 2024-2033
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. East Asia
15.3.5. South Asia
15.3.6. Oceania
15.3.7. Middle East and Africa (MEA)
15.4. Market Attractiveness Analysis By Region
16. North America Psychedelic API Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Bn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Bn) and Volume (in Kgs) Analysis and Forecast, 2024-2033
16.3.1. By Country
16.3.1.1. U.S.
16.3.1.2. Canada
16.3.2. By Product
16.3.3. By API Compounds
16.3.4. By Source
16.3.5. By Grade
16.3.6. By Application
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By API Compounds
16.4.4. By Source
16.4.5. By Grade
16.4.6. By Application
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Players – Intensity Mapping
16.8. Country Level Analysis & Forecast
16.8.1. U.S. Psychedelic API Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By API Compounds
16.8.1.2.3. By Source
16.8.1.2.4. By Grade
16.8.1.2.5. By Application
16.8.2. Canada Psychedelic API Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By API Compounds
16.8.2.2.3. By Source
16.8.2.2.4. By Grade
16.8.2.2.5. By Application
17. Latin America Psychedelic API Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Bn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Bn) and Volume (in Kgs) Analysis and Forecast, 2024-2033
17.3.1. By Country
17.3.1.1. Mexico
17.3.1.2. Brazil
17.3.1.3. Argentina
17.3.1.4. Rest of Latin America
17.3.2. By Product
17.3.3. By API Compounds
17.3.4. By Source
17.3.5. By Grade
17.3.6. By Application
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By API Compounds
17.4.4. By Source
17.4.5. By Grade
17.4.6. By Application
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Players – Intensity Mapping
17.8. Country Level Analysis & Forecast
17.8.1. Mexico Psychedelic API Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By API Compounds
17.8.1.2.3. By Source
17.8.1.2.4. By Grade
17.8.1.2.5. By Application
17.8.2. Brazil Psychedelic API Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By API Compounds
17.8.2.2.3. By Grade
17.8.2.2.4. By Application
17.8.2.2.5. By Source
17.8.3. Argentina Psychedelic API Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By API Compounds
17.8.3.2.3. By Source
17.8.3.2.4. By Grade
17.8.3.2.5. By Application
18. Europe Psychedelic API Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Bn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Bn) and Volume (in Kgs) Analysis and Forecast, 2024-2033
18.3.1. By Country
18.3.1.1. Germany
18.3.1.2. Italy
18.3.1.3. France
18.3.1.4. U.K.
18.3.1.5. Spain
18.3.1.6. BENELUX
18.3.1.7. Russia
18.3.1.8. Rest of Europe
18.3.2. By Product
18.3.3. By API Compounds
18.3.4. By Source
18.3.5. By Grade
18.3.6. By Application
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By API Compounds
18.4.4. By Source
18.4.5. By Grade
18.4.6. By Application
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Key Players – Intensity Mapping
18.8. Country Level Analysis & Forecast
18.8.1. Germany Psychedelic API Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By API Compounds
18.8.1.2.3. By Source
18.8.1.2.4. By Grade
18.8.1.2.5. By Application
18.8.2. Italy Psychedelic API Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By API Compounds
18.8.2.2.3. By Source
18.8.2.2.4. By Grade
18.8.2.2.5. By Application
18.8.3. France Psychedelic API Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By API Compounds
18.8.3.2.3. By Source
18.8.3.2.4. By Grade
18.8.3.2.5. By Application
18.8.4. U.K. Psychedelic API Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By API Compounds
18.8.4.2.3. By Source
18.8.4.2.4. By Grade
18.8.4.2.5. By Application
18.8.5. Spain Psychedelic API Market Analysis
18.8.5.1. Introduction
18.8.5.2. Market Analysis and Forecast by Market Taxonomy
18.8.5.2.1. By Product
18.8.5.2.2. By API Compounds
18.8.5.2.3. By Source
18.8.5.2.4. By Grade
18.8.5.2.5. By Application
18.8.6. BENELUX Psychedelic API Market Analysis
18.8.6.1. Introduction
18.8.6.2. Market Analysis and Forecast by Market Taxonomy
18.8.6.2.1. By Product
18.8.6.2.2. By API Compounds
18.8.6.2.3. By Source
18.8.6.2.4. By Grade
18.8.6.2.5. By Application
18.8.7. Russia Psychedelic API Market Analysis
18.8.7.1. Introduction
18.8.7.2. Market Analysis and Forecast by Market Taxonomy
18.8.7.2.1. By Product
18.8.7.2.2. By API Compounds
18.8.7.2.3. By Source
18.8.7.2.4. By Grade
18.8.7.2.5. By Application
19. East Asia Psychedelic API Market Analysis 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Historical Market Size (US$ Bn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Value (US$ Bn) and Volume (in Kgs) Analysis and Forecast, 2024-2033
19.3.1. By Country
19.3.1.1. China
19.3.1.2. Japan
19.3.1.3. South Korea
19.3.2. By Product
19.3.3. By API Compounds
19.3.4. By Source
19.3.5. By Grade
19.3.6. By Application
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By API Compounds
19.4.4. By Source
19.4.5. By Grade
19.4.6. By Application
19.5. Market Trends
19.6. Drivers and Restraints - Impact Analysis
19.7. Key Players – Intensity Mapping
19.8. Country Level Analysis & Forecast
19.8.1. China Psychedelic API Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By API Compounds
19.8.1.2.3. By Source
19.8.1.2.4. By Grade
19.8.1.2.5. By Application
19.8.2. Japan Psychedelic API Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By API Compounds
19.8.2.2.3. By Source
19.8.2.2.4. By Grade
19.8.2.2.5. By Application
19.8.3. South Korea Psychedelic API Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By API Compounds
19.8.3.2.3. By Source
19.8.3.2.4. By Grade
19.8.3.2.5. By Application
20. South Asia Psychedelic API Market Analysis 2019-2023 and Forecast 2024-2033
20.1. Introduction
20.2. Historical Market Size (US$ Bn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2019-2023
20.3. Current and Future Market Value (US$ Bn) and Volume (in Kgs) Analysis and Forecast, 2024-2033
20.3.1. By Country
20.3.1.1. India
20.3.1.2. Indonesia
20.3.1.3. Malaysia
20.3.1.4. Thailand
20.3.1.5. Rest of South Asia
20.3.2. By Product
20.3.3. By API Compounds
20.3.4. By Source
20.3.5. By Grade
20.3.6. By Application
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By API Compounds
20.4.4. By Source
20.4.5. By Grade
20.4.6. By Application
20.5. Market Trends
20.6. Drivers and Restraints - Impact Analysis
20.7. Key Players – Intensity Mapping
20.8. Country Level Analysis & Forecast
20.8.1. India Psychedelic API Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By API Compounds
20.8.1.2.3. By Source
20.8.1.2.4. By Grade
20.8.1.2.5. By Application
20.8.2. Indonesia Psychedelic API Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By API Compounds
20.8.2.2.3. By Source
20.8.2.2.4. By Grade
20.8.2.2.5. By Application
20.8.3. Malaysia Psychedelic API Market Analysis
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast by Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By API Compounds
20.8.3.2.3. By Source
20.8.3.2.4. By Grade
20.8.3.2.5. By Application
20.8.4. Thailand Psychedelic API Market Analysis
20.8.4.1. Introduction
20.8.4.2. Market Analysis and Forecast by Market Taxonomy
20.8.4.2.1. By Product
20.8.4.2.2. By API Compounds
20.8.4.2.3. By Source
20.8.4.2.4. By Grade
20.8.4.2.5. By Application
21. Oceania Psychedelic API Market 2019-2023 and Forecast 2024-2033
21.1. Introduction
21.2. Historical Market Size (US$ Bn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2019-2023
21.3. Current and Future Market Value (US$ Bn) and Volume (in Kgs) Analysis and Forecast, 2024-2033
21.3.1. By Country
21.3.1.1. Australia
21.3.1.2. New Zealand
21.3.2. By Product
21.3.3. By API Compounds
21.3.1. By Source
21.3.2. By Grade
21.3.3. By Application
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Product
21.4.3. By API Compounds
21.4.4. By Source
21.4.5. By Grade
21.4.6. By Application
21.5. Market Trends
21.6. Drivers and Restraints - Impact Analysis
21.7. Key Players – Intensity Mapping
21.8. Country Level Analysis & Forecast
21.8.1. Australia Psychedelic API Market Analysis
21.8.1.1. Introduction
21.8.1.2. Market Analysis and Forecast by Market Taxonomy
21.8.1.2.1. By Product
21.8.1.2.2. By API Compounds
21.8.1.2.3. By Source
21.8.1.2.4. By Grade
21.8.1.2.5. By Application
21.8.2. New Zealand Psychedelic API Market Analysis
21.8.2.1. Introduction
21.8.2.2. Market Analysis and Forecast by Market Taxonomy
21.8.2.2.1. By Product
21.8.2.2.2. By API Compounds
21.8.2.2.3. By Source
21.8.2.2.4. By Grade
21.8.2.2.5. By Application
22. Middle East and Africa (MEA) Psychedelic API Market Analysis 2019-2023 and Forecast 2024-2033
22.1. Introduction
22.2. Historical Market Size (US$ Bn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2019-2023
22.3. Current and Future Market Value (US$ Bn) and Volume (in Kgs) Analysis and Forecast, 2024-2033
22.3.1. By Country
22.3.1.1. GCC Countries
22.3.1.2. Turkey
22.3.1.3. North Africa
22.3.1.4. South Africa
22.3.1.5. Rest of Middle East and Africa
22.3.2. By Product
22.3.3. By API Compounds
22.3.4. By Source
22.3.5. By Grade
22.3.6. By Application
22.4. Market Attractiveness Analysis
22.4.1. By Country
22.4.2. By Product
22.4.3. By API Compounds
22.4.4. By Source
22.4.5. By Grade
22.4.6. By Application
22.5. Market Trends
22.6. Drivers and Restraints - Impact Analysis
22.7. Key Players – Intensity Mapping
22.8. Country Level Analysis & Forecast
22.8.1. GCC Countries Psychedelic API Market Analysis
22.8.1.1. Introduction
22.8.1.2. Market Analysis and Forecast by Market Taxonomy
22.8.1.2.1. By Product
22.8.1.2.2. By API Compounds
22.8.1.2.3. By Source
22.8.1.2.4. By Grade
22.8.1.2.5. By Application
22.8.2. Turkey Psychedelic API Market Analysis
22.8.2.1. Introduction
22.8.2.2. Market Analysis and Forecast by Market Taxonomy
22.8.2.2.1. By Product
22.8.2.2.2. By API Compounds
22.8.2.2.3. By Source
22.8.2.2.4. By Grade
22.8.2.2.5. By Application
22.8.3. South Africa Psychedelic API Market Analysis
22.8.3.1. Introduction
22.8.3.2. Market Analysis and Forecast by Market Taxonomy
22.8.3.2.1. By Product
22.8.3.2.2. By API Compounds
22.8.3.2.3. By Source
22.8.3.2.4. By Grade
22.8.3.2.5. By Application
22.8.4. North Africa Psychedelic API Market Analysis
22.8.4.1. Introduction
22.8.4.2. Market Analysis and Forecast by Market Taxonomy
22.8.4.2.1. By Product
22.8.4.2.2. By API Compounds
22.8.4.2.3. By Source
22.8.4.2.4. By Grade
22.8.4.2.5. By Application
23. Market Structure Analysis
23.1. Market Analysis by Tier of Companies
23.2. Market Share Analysis of Top Players
23.3. Market Presence Analysis
24. Competition Analysis
24.1. Competition Dashboard
24.2. Competition Benchmarking
24.3. Competition Deep Dive
24.3.1. Core One Labs Inc.
24.3.1.1. Overview
24.3.1.2. Product Portfolio
24.3.1.3. Sales Footprint
24.3.1.4. Key Financials
24.3.1.5. SWOT Analysis
24.3.1.6. Strategy Overview
24.3.2. Cayman Chemical Company (Matreya)
24.3.2.1. Overview
24.3.2.2. Product Portfolio
24.3.2.3. Sales Footprint
24.3.2.4. Key Financials
24.3.2.5. SWOT Analysis
24.3.2.6. Strategy Overview
24.3.3. COMPASS Pathways plc
24.3.3.1. Overview
24.3.3.2. Product Portfolio
24.3.3.3. Sales Footprint
24.3.3.4. Key Financials
24.3.3.5. SWOT Analysis
24.3.3.6. Strategy Overview
24.3.4. Beckley Psytech
24.3.4.1. Overview
24.3.4.2. Product Portfolio
24.3.4.3. Sales Footprint
24.3.4.4. Key Financials
24.3.4.5. SWOT Analysis
24.3.4.6. Strategy Overview
24.3.5. Atai Life Sciences
24.3.5.1. Overview
24.3.5.2. Product Portfolio
24.3.5.3. Sales Footprint
24.3.5.4. Key Financials
24.3.5.5. SWOT Analysis
24.3.5.6. Strategy Overview
24.3.6. Tryp Therapeutics
24.3.6.1. Overview
24.3.6.2. Product Portfolio
24.3.6.3. Sales Footprint
24.3.6.4. Key Financials
24.3.6.5. SWOT Analysis
24.3.6.6. Strategy Overview
24.3.7. Filament Health
24.3.7.1. Overview
24.3.7.2. Product Portfolio
24.3.7.3. Sales Footprint
24.3.7.4. Key Financials
24.3.7.5. SWOT Analysis
24.3.7.6. Strategy Overview
24.3.8. Ceruvia Lifesciences, LLC
24.3.8.1. Overview
24.3.8.2. Product Portfolio
24.3.8.3. Sales Footprint
24.3.8.4. Key Financials
24.3.8.5. SWOT Analysis
24.3.8.6. Strategy Overview
24.3.9. BetterLife Pharma
24.3.9.1. Overview
24.3.9.2. Product Portfolio
24.3.9.3. Sales Footprint
24.3.9.4. Key Financials
24.3.9.5. SWOT Analysis
24.3.9.6. Strategy Overview
24.3.10. Psygen Pharmaceutical
24.3.10.1. Overview
24.3.10.2. Product Portfolio
24.3.10.3. Sales Footprint
24.3.10.4. Key Financials
24.3.10.5. SWOT Analysis
24.3.10.6. Strategy Overview
24.3.11. Mindset Pharma
24.3.11.1. Overview
24.3.11.2. Product Portfolio
24.3.11.3. Sales Footprint
24.3.11.4. Key Financials
24.3.11.5. SWOT Analysis
24.3.11.6. Strategy Overview
25. Assumptions and Acronyms Used
26. Research Methodology